Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fexadyne
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fexadyne is a brand-name antihistamine medication manufactured by ARGES Life Science Limited, a pharmaceutical company based in Bangladesh. The active ingredient is fexofenadine hydrochloride, a second-generation, non-sedating selective peripheral H1-receptor antagonist. It acts as an inverse agonist that binds to and stabilizes the inactive form of the H1 histamine receptor, thereby preventing the physiological effects of histamine release. Fexadyne is indicated for the symptomatic relief of seasonal and perennial allergic rhinitis, including symptoms such as sneezing, rhinorrhea, and itchy eyes, nose, or throat, as well as for the treatment of chronic idiopathic urticaria (hives). Because it does not readily cross the blood-brain barrier, it lacks the significant sedative effects associated with first-generation antihistamines, making it suitable for daily use.
- Brand names
- Fexadyne
- Other names
- fexofenadine hydrochloride
02
Targets
HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Fexadyne.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fexadyne.